Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer

James L. Wood, Benedict Lum, Saikat Ghosh, Alexander H. Staudacher, Hari Shree Samyuktha Saravanan, Pie Huda, Alesia Ivashkevich, Peter Chandler, Michael Wheatcroft, Kristofer J. Thurecht

Open source

DOI: 10.1021/acs.molpharmaceut.6c00947
Published: 2026-10-07
Container: Molecular Pharmaceutics
Publisher: American Chemical Society (ACS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.6c00947,
  title = {Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer},
  author = {James L. Wood and Benedict Lum and Saikat Ghosh and Alexander H. Staudacher and Hari Shree Samyuktha Saravanan and Pie Huda and Alesia Ivashkevich and Peter Chandler and Michael Wheatcroft and Kristofer J. Thurecht},
  year = {2026},
  journal = {Molecular Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.6c00947},
  url = {https://doi.org/10.1021/acs.molpharmaceut.6c00947}
}

RIS

TY  - JOUR
TI  - Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer
AU  - James L. Wood
AU  - Benedict Lum
AU  - Saikat Ghosh
AU  - Alexander H. Staudacher
AU  - Hari Shree Samyuktha Saravanan
AU  - Pie Huda
AU  - Alesia Ivashkevich
AU  - Peter Chandler
AU  - Michael Wheatcroft
AU  - Kristofer J. Thurecht
PY  - 2026
JO  - Molecular Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.6c00947
UR  - https://doi.org/10.1021/acs.molpharmaceut.6c00947
ER  -

APA

Wood, J. L., Lum, B., Ghosh, S., Staudacher, A. H., Saravanan, H. S. S., Huda, P., Ivashkevich, A., Chandler, P., Wheatcroft, M., & Thurecht, K. J. (2026). Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00947

Source records

crossref · retrieved 2026-11-03T19:57:42.599Z